IL6 and breast carcinoma: Many groups since the 1980s have demonstrated that recombinant IL-6 slows proliferation of breast cancer cells in 2D cultures, with most of these studies focusing on ER+ human breast cancer cell lines like MCF7, T47D, and ZR-75-1 cells [87,88,89,90,91,92].